Ursodeoxycholic acid suppresses extent of lipid peroxidation in diseased liver in experimental cholestatic liver disease

Digestive Diseases and Sciences

Volumn 45, Issue 10, 2000, Pages 1921-1928

  Ljubuncic, Predrag ^a,b   Tanne, Zahava ^a,b   Bomzon, Arieh ^a,b  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cholestatic liver disease; Cirrhosis; Lipid peroxidation; Ursodeoxycholic acid

Indexed keywords

ALKADIENE; BILE ACID; LIPID PEROXIDE; MALONALDEHYDE; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BILE DUCT LIGATION; CHOLESTASIS; CONTROLLED STUDY; DOSE RESPONSE; LIPID PEROXIDATION; LIVER DISEASE; LIVER FUNCTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CHOLESTASIS, INTRAHEPATIC; DOSE-RESPONSE RELATIONSHIP, DRUG; LIPID PEROXIDATION; LIVER FUNCTION TESTS; MALE; RATS; RATS, SPRAGUE-DAWLEY; URSODEOXYCHOLIC ACID;

EID: 0033740305     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005615306596     Document Type: Article

References (36)

1. Liver cell necrosis: Cellular mechanisms and clinical implications
2. Molecular aspects of membrane stabilization by ursodeoxycholate
3. Evidence for involvement of oxygen free radicals in bile acid toxicity to isolated rat hepatocytes
4. Biology of disease. Free radicals and tissue injury
5. Effect of deoxycholic acid and ursodeoxycholic acid on lipid peroxidation in cultured macrophages
6. Reactive oxygen species in living systems: Source, biochemistry, and role in human disease
7. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis
8. Ursodeoxycholic acid in the treatment of liver diseases
9. Pharmacology of ursodeoxycholic acid, an enterohepatic drug
10. Ursodeoxycholate protects oxidative mitochondrial metabolism from bile acid toxicity: Dose-response study in isolated rat liver mitochondria
11. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: A mechanism of UDCA cytoprotection
12. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive species production
13. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation
14. Ursodeoxycholic acid inhibits the induction of nitric oxide synthase
15. Ursodeoxycholate inhibits induction of NOS in human intestinal epithelial cells and in vivo
16. The immunosuppressive effect of ursodeoxycholic acid: A comparative in vitro study on human peripheral blood mononuclear cells
17. Animal models of liver disease
18. In vitro vascular responsiveness to norepinephrine in experimental portal hypertension
19. Cardiovascular responses to serotonin in experimental liver disease
20. The effect of bile duct manipulation and pair-feeding on peripheral vascular neuroeffector mechanisms: In vitro studies
21. Protein measurement with the Folin phenol reagent
22. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties
23. Measuring free radical reactions in vivo
24. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent
25. Malondialdehyde determination as an index of lipid peroxidation
26. Effect of bile acids on lipid peroxidation: The role of iron
27. Effects of ursodeoxycholic acid on hepatic inflammation and histological stage in patients with primary biliary cirrhosis
28. 2 production in primary biliary cirrhosis
29. Lipid peroxidation: Its mechanism, measurement, and significance
30. Lipid peroxidation and antioxidants as biomarkers of tissue damage
31. Decreased erythrocyte membrane fluidity, and altered lipid composition in human liver disease
32. Membrane lipid changes in erythrocytes, liver and kidney in acute and chronic experimental liver disease in rats
33. The effect of bile duct ligation on bile acid metabolism in rats
34. Effects of altered cardiac membrane fluidity on β-adrenergic receptor signalling in rats with cirrhotic cardiomyopathy
35. Changes of lipid peroxide levels in blood and liver tissue of patients with obstructive jaundice
36. Elevated level of serum Mn-superoxide dismutase in patients with primary biliary cirrhosis: Possible involvement of free radicals in the pathogenesis in primary biliary cirrhosis